Table 3 –

Cost-effectiveness analysis over the short, medium, and long terms (US$, 2017).

	Average cumulative cost per patient (US$)	Average cumulative effectiveness per patient	Increment cost (US$)	Incremental effectiveness	ICER (US$)	Net monetary benefit (US$)	Incremental net benefit per patient (US$)
At one year
CHC	364.24	1.74	97.33	0.01	12,166.25	15,156.98
MHC	461.57	1.75				15,130.93	−26.05
At 10 years
CHC	2,302.51	6.63	−113.54	0.15	Cost Saving	56,770.79
MHC	2,188.97	6.78				58,220.83	1,450.04
At 20 years
CHC	4,398.71	9.35	−173.34	0.40	Cost Saving	78,909.79
MHC	4,225.37	9.75				82,647.13	3,737.34

Note: MHC refers to Multidisciplinary health care and CHC to Conventional health care. Exchange rate: 1 US$ = 18.89 MXN (Bank of Mexico, 2019). Data retrieved from the UKPDS model v 1.3. Effectiveness units: quality-adjusted life years (QALYs). Willingness to pay (WTP): 1 GDP = US $8,910 per capita per QALY (Bank of Mexico, 2019). Discount rate: 5% for cost and effectiveness. ICER: incremental cost / incremental effectiveness ratio. Net monetary benefit (NMB): WTP* QALYs - costs. Incremental net benefit per patient (INBP): net monetary benefit (NMB) of MHC - NMB of CHC.